The Centre of Excellence in Biobanking and Biomedical Research biobank.cy of the University of Cyprus is carrying out a research study in cooperation with the Medical School at the University of Cyprus, the Medical School at the University of Nicosia and the School of Sciences at the European University of Cyprus, aiming to track and evaluate the presence of antibodies against COVID-19 in the population of Cyprus.

Volunteers who have been diagnosed with COVID-19, health professionals from the Nicosia General Hospital, the Makareio Hospital of Nicosia and the Pafos General Hospital, as well as individuals from the general population were invited to participate. Results from 1,898 volunteers are under publication in the Journal of Clinical Medicine. It is possible that older people (>60 years old), male, who had symptoms or were hospitalized have higher levels of IgG antibodies, which climax during the first three months, fall dramatically until six months after and then stabilize or decrease further. Vaccinated people after two doses develop a higher level of antibodies, which falls a few months later.

The research study is continuing free of charge, with an open invitation to vaccinated volunteers, in the framework of the Η2020-CY-Biobank programme, funded by the European Commission, the Republic of Cyprus and the University of Cyprus (Grant Agreement Number 857122), as well as by the Chinese Embassy and the “Volunteer Doctors Cyprus” in part. Contact: 22-892815 or https://biobank.cy/erevna-covid-19/.